EUVIMEDEUVIMED entdecken
Open Access

Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis

Ibrahim Hacibey, Eymen Ozer, Berke Demiriz, Onuralp Nisli, Batu Akalin, Harun Ozdemir, Halil Lutfu Canat

Canadian Urological Association Journal · 04.05.2026 · 20 (9)

DOI: 10.5489/cuaj.9538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Urological Association Journal, online erschienen am 04.05.2026. Verfasst von Ibrahim Hacibey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study evaluated the diagnostic accuracy of six systemic inflammatory indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI), for identifying metastatic disease at the initial diagnosis of testicular germ cell tumors (TGCTs).

Methods

A total of 194 patients with histologically confirmed TGCTs treated between 2020 and 2025 were retrospectively analyzed. Pre-treatment complete blood counts were used to calculate inflammatory indices. Metastatic status was defined based on cross-sectional imaging, including contrast-enhanced chest, abdominal, and pelvic computed tomography. Associations with metastasis were assessed using Mann-Whitney U tests, univariate logistic regression, and receiver operating characteristic (ROC) analyses. Optimal cutoff values were determined by Youden’s index.

Results

At initial diagnosis, a total of 194 patients were included, of whom 28 (14.4%) had imaging-confirmed metastatic disease. Patients with metastases exhibited significantly higher SII, SIRI, AISI, NLR, and PLR values and significantly lower LMR values compared with non-metastatic patients (all p

Autor:innen und Institutionen

  • Department of Urology, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.

Zitieren

APA

Hacibey, I., Ozer, E., Demiriz, B., Nisli, O., Akalin, B., Ozdemir, H., & Canat, H. L. (2026). Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis. Canadian Urological Association Journal, 20(9). https://doi.org/10.5489/cuaj.9538

Vancouver

Hacibey I, Ozer E, Demiriz B, Nisli O, Akalin B, Ozdemir H, et al. Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis. Canadian Urological Association Journal. 2026;20(9). doi:10.5489/cuaj.9538

BibTeX
@article{Hacibey2026,
  author = {Hacibey, Ibrahim and Ozer, Eymen and Demiriz, Berke and Nisli, Onuralp and Akalin, Batu and Ozdemir, Harun and Canat, Halil Lutfu},
  title = {Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis},
  journal = {Canadian Urological Association Journal},
  year = {2026},
  volume = {20},
  number = {9},
  doi = {10.5489/cuaj.9538}
}
Kostenlos starten →